uniQure (QURE) Return on Capital Employed Growth (1y) (2018 - 2026)
uniQure (QURE) Return on Capital Employed Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.27 Bn | 467.47 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.18 Bn | 114.93 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.32 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 2,400.00 |
| 10 | uniQure | 2.44 Bn | 2.44 Bn | 3.34 Mn | 528.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 528.00 |
| Dec 31, 2025 | 949.00 |
| Sep 30, 2025 | 414.00 |
| Jun 30, 2025 | 556.00 |
| Mar 31, 2025 | 455.00 |
| Dec 31, 2024 | 352.00 |
| Sep 30, 2024 | -924.00 |
| Jun 30, 2024 | -1,213.00 |
| Mar 31, 2024 | -852.00 |
| Dec 31, 2023 | -1,233.00 |
| Sep 30, 2023 | 446.00 |
| Jun 30, 2023 | -149.00 |
| Mar 31, 2023 | -6,789.00 |
| Dec 31, 2022 | -6,517.00 |
| Sep 30, 2022 | -6,838.00 |
| Jun 30, 2022 | -7,945.00 |
| Mar 31, 2022 | 8,308.00 |
| Dec 31, 2021 | 8,056.00 |
| Sep 30, 2021 | 8,559.00 |
| Jun 30, 2021 | 9,400.00 |